Plethico Pharmaceuticals approves up to $40 million in convertibles

By Devika Patel

Knoxville, Tenn., March 31 - Plethico Pharmaceuticals Ltd. notified the Bombay Stock Exchange that it approved plans to issue up to $40 million in foreign currency convertible bonds at an extraordinary general meeting on March 31.

Securities may include Global Depositary Receipts, equity shares or other equity-linked instruments.

Plethico is a Mumbai, India-based pharmaceuticals firm.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.